NCT06089031 Belgian Registry on Coronary Function Testing
| NCT ID | NCT06089031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Coronary Microvascular Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2021-10-18 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2021-10-18 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective, multicenter registy is to describe the 'real-world' use of coronary function tests, which may consist of bolus thermodilution measurements of coronary microvascular function and/or invasive vasoreactivity tests with acetylcholine, in the current Belgian routine practice. The main questions it aims to answer are: * how frequent are coronary function tests performed * what is the indication for coronary function tests * what is the frequency of coronary microvascular dysfunction * what is the frequency of coronary artery vasospasm From each participant, data will be collected from their medical files concerning cardiovascular risk factors, relevant past medical history, non-invasive tests, procedural data, and follow-up data from routine in-patient visits. Their are no specific study visits. Optionally, patients will be asked to fill in questionnaires about anginal symptoms and quality of life.
Eligibility Criteria
Inclusion Criteria: * Patient scheduled for coronary function test, comprising of intracoronary bolus thermodilution measurements of microvascular function, and/or intracoronary vasoreactivity tests with acetylcholine. * Subject understands the study requirements and provides written informed consent. Exclusion Criteria: * Subject is participating in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation. * Subject intends to participate in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation. * Documented or suspected pregnancy. * Inability to provide written informed consent.
Frequently Asked Questions
Who can join the NCT06089031 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Microvascular Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06089031 currently recruiting?
Yes, NCT06089031 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Antwerp to inquire about joining.
Where is the NCT06089031 trial being conducted?
This trial is being conducted at Deurne, Belgium, Mechelen, Belgium, Hasselt, Belgium, Aalst, Belgium and 9 additional locations.
Who is sponsoring the NCT06089031 clinical trial?
NCT06089031 is sponsored by University Hospital, Antwerp. The trial plans to enroll 650 participants.